-
1
-
-
51049098138
-
Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer
-
Locke, J. A.; Guns, E. S.; Lubik, A. A.; Adomat, H. H.; Hendy, S. C.; Wood, C. A.; Ettinger, S. L.; Gleave, M. E.; Nelson, C. C. Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer Cancer Res. 2008, 68, 6407-6415
-
(2008)
Cancer Res.
, vol.68
, pp. 6407-6415
-
-
Locke, J.A.1
Guns, E.S.2
Lubik, A.A.3
Adomat, H.H.4
Hendy, S.C.5
Wood, C.A.6
Ettinger, S.L.7
Gleave, M.E.8
Nelson, C.C.9
-
2
-
-
68049140791
-
Starving the addiction: New opportunities for durable suppression of AR signaling in prostate cancer
-
Knudsen, K. E.; Scher, H. I. Starving the addiction: new opportunities for durable suppression of AR signaling in prostate cancer Clin. Cancer Res. 2009, 15, 4792-4798
-
(2009)
Clin. Cancer Res.
, vol.15
, pp. 4792-4798
-
-
Knudsen, K.E.1
Scher, H.I.2
-
3
-
-
77952554163
-
Partners in crime: Deregulation of AR activity and androgen synthesis in prostate cancer
-
Knudsen, K. E.; Penning, T. M. Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer Trends Endocrinol. Metab. 2010, 21, 315-324
-
(2010)
Trends Endocrinol. Metab.
, vol.21
, pp. 315-324
-
-
Knudsen, K.E.1
Penning, T.M.2
-
4
-
-
33645056171
-
Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer
-
Stanbrough, M.; Bubley, G. J.; Ross, K.; Golub, T. R.; Rubin, M. A.; Penning, T. M.; Febbo, P. G.; Balk, S. P. Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer Cancer Res. 2006, 66, 2815-2825
-
(2006)
Cancer Res.
, vol.66
, pp. 2815-2825
-
-
Stanbrough, M.1
Bubley, G.J.2
Ross, K.3
Golub, T.R.4
Rubin, M.A.5
Penning, T.M.6
Febbo, P.G.7
Balk, S.P.8
-
5
-
-
49249119358
-
Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth
-
Montgomery, R. B.; Mostaghel, E. A.; Vessella, R.; Hess, D. L.; Kalhorn, T. F.; Higano, C. S.; True, L. D.; Nelson, P. S. Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth Cancer Res. 2008, 68, 4447-4454
-
(2008)
Cancer Res.
, vol.68
, pp. 4447-4454
-
-
Montgomery, R.B.1
Mostaghel, E.A.2
Vessella, R.3
Hess, D.L.4
Kalhorn, T.F.5
Higano, C.S.6
True, L.D.7
Nelson, P.S.8
-
6
-
-
76249096762
-
Evidence of limited contributions for intratumoral steroidogenesis in prostate cancer
-
Hofland, J.; van Weerden, W. M.; Dits, N. F.; Steenbergen, J.; van Leenders, G. J.; Jenster, G.; Schroder, F. H.; de Jong, F. H. Evidence of limited contributions for intratumoral steroidogenesis in prostate cancer Cancer Res. 2010, 70, 1256-64
-
(2010)
Cancer Res.
, vol.70
, pp. 1256-1264
-
-
Hofland, J.1
Van Weerden, W.M.2
Dits, N.F.3
Steenbergen, J.4
Van Leenders, G.J.5
Jenster, G.6
Schroder, F.H.7
De Jong, F.H.8
-
7
-
-
3042784503
-
Hormonal impact of the 17α-hydroxylase/C(17,20)-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer
-
O'Donnell, A.; Judson, I.; Dowsett, M.; Raynaud, F.; Dearnaley, D.; Mason, M.; Harland, S.; Robbins, A.; Halbert, G.; Nutley, B.; Jarman, M. Hormonal impact of the 17α-hydroxylase/C(17,20)-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer Br. J. Cancer 2004, 90, 2317-2325
-
(2004)
Br. J. Cancer
, vol.90
, pp. 2317-2325
-
-
O'Donnell, A.1
Judson, I.2
Dowsett, M.3
Raynaud, F.4
Dearnaley, D.5
Mason, M.6
Harland, S.7
Robbins, A.8
Halbert, G.9
Nutley, B.10
Jarman, M.11
-
8
-
-
68949094223
-
Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer
-
Attard, G.; Reid, A. H.; A'Hern, R.; Parker, C.; Oommen, N. B.; Folkerd, E.; Messiou, C.; Molife, L. R.; Maier, G.; Thompson, E.; Olmos, D.; Sinha, R.; Lee, G.; Dowsett, M.; Kaye, S. B.; Dearnaley, D.; Kheoh, T.; Molina, A.; de Bono, J. S. Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer J. Clin. Oncol. 2009, 27, 3742-3748
-
(2009)
J. Clin. Oncol.
, vol.27
, pp. 3742-3748
-
-
Attard, G.1
Reid, A.H.2
A'Hern, R.3
Parker, C.4
Oommen, N.B.5
Folkerd, E.6
Messiou, C.7
Molife, L.R.8
Maier, G.9
Thompson, E.10
Olmos, D.11
Sinha, R.12
Lee, G.13
Dowsett, M.14
Kaye, S.B.15
Dearnaley, D.16
Kheoh, T.17
Molina, A.18
De Bono, J.S.19
-
9
-
-
77951518711
-
Significant and sustained antitumor activity in post-docetaxel, castration-resistant prostate cancer with the CYP17 inhibitor abiraterone acetate
-
Reid, A. H.; Attard, G.; Danila, D. C.; Oommen, N. B.; Olmos, D.; Fong, P. C.; Molife, L. R.; Hunt, J.; Messiou, C.; Parker, C.; Dearnaley, D.; Swennenhuis, J. F.; Terstappen, L. W.; Lee, G.; Kheoh, T.; Molina, A.; Ryan, C. J.; Small, E.; Scher, H. I.; De Bono, J. S. Significant and sustained antitumor activity in post-docetaxel, castration-resistant prostate cancer with the CYP17 inhibitor abiraterone acetate J. Clin. Oncol. 2010, 28, 1489-1495
-
(2010)
J. Clin. Oncol.
, vol.28
, pp. 1489-1495
-
-
Reid, A.H.1
Attard, G.2
Danila, D.C.3
Oommen, N.B.4
Olmos, D.5
Fong, P.C.6
Molife, L.R.7
Hunt, J.8
Messiou, C.9
Parker, C.10
Dearnaley, D.11
Swennenhuis, J.F.12
Terstappen, L.W.13
Lee, G.14
Kheoh, T.15
Molina, A.16
Ryan, C.J.17
Small, E.18
Scher, H.I.19
De Bono, J.S.20
more..
-
10
-
-
79957443342
-
Abiraterone and increased survival in metastatic prostate cancer
-
de Bono, J. S.; Logothetis, C. J.; Molina, A.; Fizazi, K.; North, S.; Chu, L.; Chi, K. N.; Jones, R. J.; Goodman, O. B., Jr.; Saad, F.; Staffurth, J. N.; Mainwaring, P.; Harland, S.; Flaig, T. W.; Hutson, T. E.; Cheng, T.; Patterson, H.; Hainsworth, J. D.; Ryan, C. J.; Sternberg, C. N.; Ellard, S. L.; Flechon, A.; Saleh, M.; Scholz, M.; Efstathiou, E.; Zivi, A.; Bianchini, D.; Loriot, Y.; Chieffo, N.; Kheoh, T.; Haqq, C. M.; Scher, H. I. Abiraterone and increased survival in metastatic prostate cancer N. Engl. J. Med. 2011, 364, 1995-2005
-
(2011)
N. Engl. J. Med.
, vol.364
, pp. 1995-2005
-
-
De Bono, J.S.1
Logothetis, C.J.2
Molina, A.3
Fizazi, K.4
North, S.5
Chu, L.6
Chi, K.N.7
Jones, R.J.8
Goodman Jr., O.B.9
Saad, F.10
Staffurth, J.N.11
Mainwaring, P.12
Harland, S.13
Flaig, T.W.14
Hutson, T.E.15
Cheng, T.16
Patterson, H.17
Hainsworth, J.D.18
Ryan, C.J.19
Sternberg, C.N.20
Ellard, S.L.21
Flechon, A.22
Saleh, M.23
Scholz, M.24
Efstathiou, E.25
Zivi, A.26
Bianchini, D.27
Loriot, Y.28
Chieffo, N.29
Kheoh, T.30
Haqq, C.M.31
Scher, H.I.32
more..
-
11
-
-
0028972025
-
15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma
-
Forman, B. M.; Tontonoz, P.; Chen, J.; Brun, R. P.; Spiegelman, B. M.; Evans, R. M. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma Cell 1995, 83, 803-12
-
(1995)
Cell
, vol.83
, pp. 803-812
-
-
Forman, B.M.1
Tontonoz, P.2
Chen, J.3
Brun, R.P.4
Spiegelman, B.M.5
Evans, R.M.6
-
12
-
-
0031759084
-
2 11-ketoreductase activity
-
2 11-ketoreductase activity J. Biochem. 1998, 124, 940-946
-
(1998)
J. Biochem.
, vol.124
, pp. 940-946
-
-
Matsuura, K.1
Shiraishi, H.2
Hara, A.3
Sato, K.4
Deyashiki, Y.5
Ninomiya, M.6
Sakai, S.7
-
13
-
-
0032700671
-
CDNA cloning, expression and characterization of human prostaglandin F synthase
-
Suzuki-Yamamoto, T.; Nishizawa, M.; Fukui, M.; Okuda-Ashitaka, E.; Nakajima, T.; Ito, S.; Watanabe, K. cDNA cloning, expression and characterization of human prostaglandin F synthase FEBS Lett. 1999, 462, 335-40
-
(1999)
FEBS Lett.
, vol.462
, pp. 335-340
-
-
Suzuki-Yamamoto, T.1
Nishizawa, M.2
Fukui, M.3
Okuda-Ashitaka, E.4
Nakajima, T.5
Ito, S.6
Watanabe, K.7
-
14
-
-
0037439967
-
The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase- dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs
-
Desmond, J. C.; Mountford, J. C.; Drayson, M. T.; Walker, E. A.; Hewison, M.; Ride, J. P.; Luong, Q. T.; Hayden, R. E.; Vanin, E. F.; Bunce, C. M. The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs Cancer Res. 2003, 63, 505-512
-
(2003)
Cancer Res.
, vol.63
, pp. 505-512
-
-
Desmond, J.C.1
Mountford, J.C.2
Drayson, M.T.3
Walker, E.A.4
Hewison, M.5
Ride, J.P.6
Luong, Q.T.7
Hayden, R.E.8
Vanin, E.F.9
Bunce, C.M.10
-
15
-
-
33644954823
-
Peroxisome proliferator-activated receptor gamma in malignant diseases
-
Wang, T.; Xu, J.; Yu, X.; Yang, R.; Han, Z. C. Peroxisome proliferator-activated receptor gamma in malignant diseases Crit. Rev. Oncol. Hematol. 2006, 58, 1-14
-
(2006)
Crit. Rev. Oncol. Hematol.
, vol.58
, pp. 1-14
-
-
Wang, T.1
Xu, J.2
Yu, X.3
Yang, R.4
Han, Z.C.5
-
16
-
-
0032510704
-
Expression and characterization of four recombinant human dihydrodiol dehydrogenase isoforms: Oxidation of trans -7, 8-dihydroxy-7,8-dihydrobenzo[ a ]pyrene to the activated o -quinone metabolite benzo[ a ]pyrene-7,8-dione
-
Burczynski, M. E.; Harvey, R. G.; Penning, T. M. Expression and characterization of four recombinant human dihydrodiol dehydrogenase isoforms: oxidation of trans -7, 8-dihydroxy-7,8-dihydrobenzo[ a ]pyrene to the activated o -quinone metabolite benzo[ a ]pyrene-7,8-dione Biochemistry 1998, 37, 6781-6790
-
(1998)
Biochemistry
, vol.37
, pp. 6781-6790
-
-
Burczynski, M.E.1
Harvey, R.G.2
Penning, T.M.3
-
17
-
-
0034287545
-
Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: Functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones
-
Penning, T. M.; Burczynski, M. E.; Jez, J. M.; Hung, C. F.; Lin, H. K.; Ma, H.; Moore, M.; Palackal, N.; Ratnam, K. Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones Biochem. J. 2000, 351, 67-77
-
(2000)
Biochem. J.
, vol.351
, pp. 67-77
-
-
Penning, T.M.1
Burczynski, M.E.2
Jez, J.M.3
Hung, C.F.4
Lin, H.K.5
Ma, H.6
Moore, M.7
Palackal, N.8
Ratnam, K.9
-
18
-
-
0037661059
-
Human type 3α-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells
-
Rizner, T. L.; Lin, H. K.; Peehl, D. M.; Steckelbroeck, S.; Bauman, D. R.; Penning, T. M. Human type 3α-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells Endocrinology 2003, 144, 2922-2932
-
(2003)
Endocrinology
, vol.144
, pp. 2922-2932
-
-
Rizner, T.L.1
Lin, H.K.2
Peehl, D.M.3
Steckelbroeck, S.4
Bauman, D.R.5
Penning, T.M.6
-
19
-
-
1642305724
-
Human cytosolic 3α-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3β-hydroxysteroid dehydrogenase activity: Implications for steroid hormone metabolism and action
-
Steckelbroeck, S.; Jin, Y.; Gopishetty, S.; Oyesanmi, B.; Penning, T. M. Human cytosolic 3α-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3β-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action J. Biol. Chem. 2004, 279, 10784-10795
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 10784-10795
-
-
Steckelbroeck, S.1
Jin, Y.2
Gopishetty, S.3
Oyesanmi, B.4
Penning, T.M.5
-
20
-
-
84863230589
-
Development of potent and selective inhibitors of Aldo-Keto Reductase 1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase) based on N -phenyl- aminobenzoates and their structure-activity relationships
-
Adeniji, A. O.; Twenter, B. M.; Byrns, M. C.; Jin, Y.; Chen, M.; Winkler, J. D.; Penning, T. M. Development of potent and selective inhibitors of Aldo-Keto Reductase 1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase) based on N -phenyl-aminobenzoates and their structure-activity relationships J. Med. Chem. 2012, 55, 2311-23
-
(2012)
J. Med. Chem.
, vol.55
, pp. 2311-2323
-
-
Adeniji, A.O.1
Twenter, B.M.2
Byrns, M.C.3
Jin, Y.4
Chen, M.5
Winkler, J.D.6
Penning, T.M.7
-
21
-
-
79951726954
-
Discovery of substituted 3-(phenylamino)benzoic acids as potent and selective inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3)
-
Adeniji, A. O.; Twenter, B. M.; Byrns, M. C.; Jin, Y.; Winkler, J. D.; Penning, T. M. Discovery of substituted 3-(phenylamino)benzoic acids as potent and selective inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) Bioorg. Med. Chem. Lett. 2011, 21, 1464-8
-
(2011)
Bioorg. Med. Chem. Lett.
, vol.21
, pp. 1464-1468
-
-
Adeniji, A.O.1
Twenter, B.M.2
Byrns, M.C.3
Jin, Y.4
Winkler, J.D.5
Penning, T.M.6
-
22
-
-
84860493930
-
Crystal structures of AKR1C3 containing an N -(aryl)amino-benzoate inhibitor and a bifunctional AKR1C3 inhibitor and androgen receptor antagonist. Therapeutic leads for castrate resistant prostate cancer
-
Chen, M.; Adeniji, A. O.; Twenter, B. M.; Winkler, J. D.; Christianson, D. W.; Penning, T. M. Crystal structures of AKR1C3 containing an N -(aryl)amino-benzoate inhibitor and a bifunctional AKR1C3 inhibitor and androgen receptor antagonist. Therapeutic leads for castrate resistant prostate cancer Bioorg. Med. Chem. Lett. 2012, 22, 3492-7
-
(2012)
Bioorg. Med. Chem. Lett.
, vol.22
, pp. 3492-3497
-
-
Chen, M.1
Adeniji, A.O.2
Twenter, B.M.3
Winkler, J.D.4
Christianson, D.W.5
Penning, T.M.6
-
23
-
-
84860321938
-
Selective inhibition of human type-5 17β-hydroxysteroid dehydrogenase (AKR1C3) by baccharin, a component of Brazilian propolis
-
Endo, S.; Matsunaga, T.; Kanamori, A.; Otsuji, Y.; Nagai, H.; Sundaram, K.; El-Kabbani, O.; Toyooka, N.; Ohta, S.; Hara, A. Selective inhibition of human type-5 17β-hydroxysteroid dehydrogenase (AKR1C3) by baccharin, a component of Brazilian propolis J. Nat. Prod. 2012, 75, 716-21
-
(2012)
J. Nat. Prod.
, vol.75
, pp. 716-721
-
-
Endo, S.1
Matsunaga, T.2
Kanamori, A.3
Otsuji, Y.4
Nagai, H.5
Sundaram, K.6
El-Kabbani, O.7
Toyooka, N.8
Ohta, S.9
Hara, A.10
-
24
-
-
84866336135
-
3-(3,4-Dihydroisoquinolin-2(1 H)-ylsulfonyl)benzoic acids: Highly potent and selective inhibitors of the type 5 17β-hydroxysteroid dehydrogenase AKR1C3
-
Jamieson, S. M.; Brooke, D. G.; Heinrich, D.; Atwell, G. J.; Silva, S.; Hamilton, E. J.; Turnbull, A. P.; Rigoreau, L. J.; Trivier, E.; Soudy, C.; Samlal, S. S.; Owen, P. J.; Schroeder, E.; Raynham, T.; Flanagan, J. U.; Denny, W. A. 3-(3,4-Dihydroisoquinolin-2(1 H)-ylsulfonyl)benzoic acids: highly potent and selective inhibitors of the type 5 17β-hydroxysteroid dehydrogenase AKR1C3 J. Med. Chem. 2012, 55, 7746-58
-
(2012)
J. Med. Chem.
, vol.55
, pp. 7746-7758
-
-
Jamieson, S.M.1
Brooke, D.G.2
Heinrich, D.3
Atwell, G.J.4
Silva, S.5
Hamilton, E.J.6
Turnbull, A.P.7
Rigoreau, L.J.8
Trivier, E.9
Soudy, C.10
Samlal, S.S.11
Owen, P.J.12
Schroeder, E.13
Raynham, T.14
Flanagan, J.U.15
Denny, W.A.16
-
25
-
-
84865506661
-
N -Benzoyl anthranilic acid derivatives as selective inhibitors of aldo-keto reductase AKR1C3
-
Sinreih, M.; Sosic, I.; Beranic, N.; Turk, S.; Adeniji, A. O.; Penning, T. M.; Rizner, T. L.; Gobec, S. N -Benzoyl anthranilic acid derivatives as selective inhibitors of aldo-keto reductase AKR1C3 Bioorg. Med. Chem. Lett. 2012, 22, 5948-51
-
(2012)
Bioorg. Med. Chem. Lett.
, vol.22
, pp. 5948-5951
-
-
Sinreih, M.1
Sosic, I.2
Beranic, N.3
Turk, S.4
Adeniji, A.O.5
Penning, T.M.6
Rizner, T.L.7
Gobec, S.8
-
26
-
-
84866324534
-
Selective inhibitors of aldo-keto reductases AKR1C1 and AKR1C3 discovered by virtual screening of a fragment library
-
Brozic, P.; Turk, S.; Adeniji, A. O.; Konc, J.; Janezic, D.; Penning, T. M.; Lanisnik Rizner, T.; Gobec, S. Selective inhibitors of aldo-keto reductases AKR1C1 and AKR1C3 discovered by virtual screening of a fragment library J. Med. Chem. 2012, 55, 7417-24
-
(2012)
J. Med. Chem.
, vol.55
, pp. 7417-7424
-
-
Brozic, P.1
Turk, S.2
Adeniji, A.O.3
Konc, J.4
Janezic, D.5
Penning, T.M.6
Lanisnik Rizner, T.7
Gobec, S.8
-
27
-
-
11244348953
-
Development of nonsteroidal anti-inflammatory drug analogs and steroid carboxylates selective for human aldo-keto reductase isoforms: Potential antineoplastic agents that work independently of cyclooxygenase isozymes
-
Bauman, D. R.; Rudnick, S. I.; Szewczuk, L. M.; Jin, Y.; Gopishetty, S.; Penning, T. M. Development of nonsteroidal anti-inflammatory drug analogs and steroid carboxylates selective for human aldo-keto reductase isoforms: potential antineoplastic agents that work independently of cyclooxygenase isozymes Mol. Pharmacol. 2005, 67, 60-68
-
(2005)
Mol. Pharmacol.
, vol.67
, pp. 60-68
-
-
Bauman, D.R.1
Rudnick, S.I.2
Szewczuk, L.M.3
Jin, Y.4
Gopishetty, S.5
Penning, T.M.6
-
28
-
-
0025864249
-
Isolation and partial characterization of a full-length cDNA clone for 3α-hydroxysteroid dehydrogenase: A potential target enzyme for nonsteroidal anti-inflammatory drugs
-
Pawlowski, J.; Huizinga, M.; Penning, T. M. Isolation and partial characterization of a full-length cDNA clone for 3α-hydroxysteroid dehydrogenase: a potential target enzyme for nonsteroidal anti-inflammatory drugs Agents Actions 1991, 34, 289-293
-
(1991)
Agents Actions
, vol.34
, pp. 289-293
-
-
Pawlowski, J.1
Huizinga, M.2
Penning, T.M.3
-
29
-
-
0343299437
-
+-linked oxidoreductase from rat liver cytosol by steroidal and nonsteroidal anti-inflammatory agents and by prostaglandins
-
+-linked oxidoreductase from rat liver cytosol by steroidal and nonsteroidal anti-inflammatory agents and by prostaglandins Proc. Natl. Acad. Sci. U.S.A. 1983, 80, 4504-4508
-
(1983)
Proc. Natl. Acad. Sci. U.S.A.
, vol.80
, pp. 4504-4508
-
-
Penning, T.M.1
Talalay, P.2
-
30
-
-
80054021222
-
Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors
-
Cai, C.; Chen, S.; Ng, P.; Bubley, G. J.; Nelson, P. S.; Mostaghel, E. A.; Marck, B.; Matsumoto, A. M.; Simon, N. I.; Wang, H.; Balk, S. P. Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors Cancer Res. 2011, 71, 6503-13
-
(2011)
Cancer Res.
, vol.71
, pp. 6503-6513
-
-
Cai, C.1
Chen, S.2
Ng, P.3
Bubley, G.J.4
Nelson, P.S.5
Mostaghel, E.A.6
Marck, B.7
Matsumoto, A.M.8
Simon, N.I.9
Wang, H.10
Balk, S.P.11
-
31
-
-
37349047898
-
An indomethacin analogue, N -(4-chlorobenzoyl)-melatonin, is a selective inhibitor of aldo-keto reductase 1C3 (type 2 3α-HSD, type 5 17β-HSD, and prostaglandin F synthase), a potential target for the treatment of hormone dependent and hormone independent malignancies
-
Byrns, M. C.; Steckelbroeck, S.; Penning, T. M. An indomethacin analogue, N -(4-chlorobenzoyl)-melatonin, is a selective inhibitor of aldo-keto reductase 1C3 (type 2 3α-HSD, type 5 17β-HSD, and prostaglandin F synthase), a potential target for the treatment of hormone dependent and hormone independent malignancies Biochem. Pharmacol. 2008, 75, 484-493
-
(2008)
Biochem. Pharmacol.
, vol.75
, pp. 484-493
-
-
Byrns, M.C.1
Steckelbroeck, S.2
Penning, T.M.3
-
32
-
-
27644575900
-
Indolyl esters and amides related to indomethacin are selective COX-2 inhibitors
-
Kalgutkar, A. S.; Crews, B. C.; Saleh, S.; Prudhomme, D.; Marnett, L. J. Indolyl esters and amides related to indomethacin are selective COX-2 inhibitors Bioorg. Med. Chem. 2005, 13, 6810-22
-
(2005)
Bioorg. Med. Chem.
, vol.13
, pp. 6810-6822
-
-
Kalgutkar, A.S.1
Crews, B.C.2
Saleh, S.3
Prudhomme, D.4
Marnett, L.J.5
-
33
-
-
84875697212
-
Development of potent and selective indomethacin analogs for the inhibition of AKR1C3 in castrate-resistant prostate cancer
-
Adeniji, A. O.; Liedtke, A.; Byrns, M. C.; Jin, Y.; Marnett, L. J.; Penning, T. M. Development of potent and selective indomethacin analogs for the inhibition of AKR1C3 in castrate-resistant prostate cancer Endocr. Rev. 2012, 33, SAT-537
-
(2012)
Endocr. Rev.
, vol.33
, pp. 537
-
-
Adeniji, A.O.1
Liedtke, A.2
Byrns, M.C.3
Jin, Y.4
Marnett, L.J.5
Penning, T.M.6
-
34
-
-
84867572903
-
Straightforward protocol for the efficient synthesis of varied N1-acylated (aza)indole 2-/3-alkanoic acids and esters: Optimization and scale-up
-
Liedtke, A. J.; Kim, K.; Stec, D. F.; Sulikowski, G. A.; Marnett, L. J. Straightforward protocol for the efficient synthesis of varied N1-acylated (aza)indole 2-/3-alkanoic acids and esters: optimization and scale-up Tetrahedron 2012, 68, 10049-10058
-
(2012)
Tetrahedron
, vol.68
, pp. 10049-10058
-
-
Liedtke, A.J.1
Kim, K.2
Stec, D.F.3
Sulikowski, G.A.4
Marnett, L.J.5
-
35
-
-
0014228967
-
1-Acyl-indoles. II. A new syntheses of 1-(ion-chlorobenzoyl)-5-methoxy-3- indolylacetic acid and its polymorphism
-
Yamamoto, H. 1-Acyl-indoles. II. A new syntheses of 1-(ion-chlorobenzoyl) -5-methoxy-3-indolylacetic acid and its polymorphism Chem. Pharm. Bull. 1968, 16, 17-19
-
(1968)
Chem. Pharm. Bull.
, vol.16
, pp. 17-19
-
-
Yamamoto, H.1
-
36
-
-
84875717127
-
-
US patent 20050234244.
-
Bartolini, W.; Cali, B. M.; Chen, B.; Chien, Y.-T.; Currie, M. G.; Milne, G. T.; Pearson, J. P.; Talley, J. J.; Zimmerman, C. Synthesis of Acylindole COX-2 and FAAH Inhibitors. US patent 20050234244, 2005.
-
(2005)
Synthesis of Acylindole COX-2 and FAAH Inhibitors
-
-
Bartolini, W.1
Cali, B.M.2
Chen, B.3
Chien, Y.-T.4
Currie, M.G.5
Milne, G.T.6
Pearson, J.P.7
Talley, J.J.8
Zimmerman, C.9
-
37
-
-
12944267607
-
An unusual Fischer indole synthesis with 4-keto acids: An indole incorporating the terminal hydrazine nitrogen
-
Conn, R. S. E.; Douglas, A. W.; Karady, S.; Corley, E. G.; Lovell, A. V.; Shinkai, I. An unusual Fischer indole synthesis with 4-keto acids: an indole incorporating the terminal hydrazine nitrogen J. Org. Chem. 1990, 55, 2908-13
-
(1990)
J. Org. Chem.
, vol.55
, pp. 2908-2913
-
-
Conn, R.S.E.1
Douglas, A.W.2
Karady, S.3
Corley, E.G.4
Lovell, A.V.5
Shinkai, I.6
-
38
-
-
0142026597
-
Total Synthesis of mappicine ketone (Nothapodytine B) by means of sulfur-directed 5-exo-selective aryl radical cyclization onto enamides
-
Kato, I.; Higashimoto, M.; Tamura, O.; Ishibashi, H. Total Synthesis of mappicine ketone (Nothapodytine B) by means of sulfur-directed 5-exo-selective aryl radical cyclization onto enamides J. Org. Chem. 2003, 68, 7983-7989
-
(2003)
J. Org. Chem.
, vol.68
, pp. 7983-7989
-
-
Kato, I.1
Higashimoto, M.2
Tamura, O.3
Ishibashi, H.4
-
39
-
-
84987367640
-
Selectivity in the Fischer indolization of phenylhydrazones derived from 3-ketocyclohexanecarboxylic acid
-
Allen, G. R., Jr. Selectivity in the Fischer indolization of phenylhydrazones derived from 3-ketocyclohexanecarboxylic acid J. Heterocycl. Chem. 1970, 7, 239-41
-
(1970)
J. Heterocycl. Chem.
, vol.7
, pp. 239-241
-
-
Allen Jr., G.R.1
-
40
-
-
21244454119
-
2-Arylpropionic CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive CXCL8 inhibitors
-
Allegretti, M.; Bertini, R.; Cesta, M. C.; Bizzarri, C.; Di Bitondo, R.; Di Cioccio, V.; Galliera, E.; Berdini, V.; Topai, A.; Zampella, G.; Russo, V.; Di Bello, N.; Nano, G.; Nicolini, L.; Locati, M.; Fantucci, P.; Florio, S.; Colotta, F. 2-Arylpropionic CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive CXCL8 inhibitors J. Med. Chem. 2005, 48, 4312-4331
-
(2005)
J. Med. Chem.
, vol.48
, pp. 4312-4331
-
-
Allegretti, M.1
Bertini, R.2
Cesta, M.C.3
Bizzarri, C.4
Di Bitondo, R.5
Di Cioccio, V.6
Galliera, E.7
Berdini, V.8
Topai, A.9
Zampella, G.10
Russo, V.11
Di Bello, N.12
Nano, G.13
Nicolini, L.14
Locati, M.15
Fantucci, P.16
Florio, S.17
Colotta, F.18
-
41
-
-
33845924163
-
Novel silicon-containing drugs derived from the indomethacin scaffold: Synthesis, characterization and evaluation of biological activity
-
Bikzhanova, G. A.; Toulokhonova, I. S.; Gately, S.; West, R. Novel silicon-containing drugs derived from the indomethacin scaffold: Synthesis, characterization and evaluation of biological activity Silicon Chem. 2007, 3, 209-217
-
(2007)
Silicon Chem.
, vol.3
, pp. 209-217
-
-
Bikzhanova, G.A.1
Toulokhonova, I.S.2
Gately, S.3
West, R.4
-
42
-
-
79951512104
-
Accidental discovery of a 'longer-range' vinylogous Pummerer-type lactonization: Formation of sulindac sulfide lactone from sulindac
-
Halder, S.; Satyam, A. Accidental discovery of a 'longer-range' vinylogous Pummerer-type lactonization: Formation of sulindac sulfide lactone from sulindac Tetrahedron Lett. 2011, 52, 1179-1182
-
(2011)
Tetrahedron Lett.
, vol.52
, pp. 1179-1182
-
-
Halder, S.1
Satyam, A.2
-
43
-
-
8244255009
-
Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor
-
Riendeau, D.; Percival, M. D.; Boyce, S.; Brideau, C.; Charleson, S.; Cromlish, W.; Ethier, D.; Evans, J.; Falgueyret, J. P.; Ford-Hutchinson, A. W.; Gordon, R.; Greig, G.; Gresser, M.; Guay, J.; Kargman, S.; Leger, S.; Mancini, J. A.; O'Neill, G.; Ouellet, M.; Rodger, I. W.; Therien, M.; Wang, Z.; Webb, J. K.; Wong, E.; Chan, C. C. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor Br. J. Pharmacol. 1997, 121, 105-17
-
(1997)
Br. J. Pharmacol.
, vol.121
, pp. 105-117
-
-
Riendeau, D.1
Percival, M.D.2
Boyce, S.3
Brideau, C.4
Charleson, S.5
Cromlish, W.6
Ethier, D.7
Evans, J.8
Falgueyret, J.P.9
Ford-Hutchinson, A.W.10
Gordon, R.11
Greig, G.12
Gresser, M.13
Guay, J.14
Kargman, S.15
Leger, S.16
Mancini, J.A.17
O'Neill, G.18
Ouellet, M.19
Rodger, I.W.20
Therien, M.21
Wang, Z.22
Webb, J.K.23
Wong, E.24
Chan, C.C.25
more..
-
44
-
-
84858036311
-
Cyclooxygenase-1-selective inhibitors based on the (E)-2′-des- methyl-sulindac sulfide scaffold
-
Liedtke, A. J.; Crews, B. C.; Daniel, C. M.; Blobaum, A. L.; Kingsley, P. J.; Ghebreselasie, K.; Marnett, L. J. Cyclooxygenase-1-selective inhibitors based on the (E)-2′-des-methyl-sulindac sulfide scaffold J. Med. Chem. 2012, 55, 2287-2300
-
(2012)
J. Med. Chem.
, vol.55
, pp. 2287-2300
-
-
Liedtke, A.J.1
Crews, B.C.2
Daniel, C.M.3
Blobaum, A.L.4
Kingsley, P.J.5
Ghebreselasie, K.6
Marnett, L.J.7
-
45
-
-
34548630613
-
Desmethyl derivatives of indomethacin and sulindac as probes for cyclooxygenase-dependent biology
-
Felts, A. S.; Ji, C.; Stafford, J. B.; Crews, B. C.; Kingsley, P. J.; Rouzer, C. A.; Washington, M. K.; Subbaramaiah, K.; Siegel, B. S.; Young, S. M.; Dannenberg, A. J.; Marnett, L. J. Desmethyl derivatives of indomethacin and sulindac as probes for cyclooxygenase-dependent biology ACS Chem. Biol. 2007, 2, 479-483
-
(2007)
ACS Chem. Biol.
, vol.2
, pp. 479-483
-
-
Felts, A.S.1
Ji, C.2
Stafford, J.B.3
Crews, B.C.4
Kingsley, P.J.5
Rouzer, C.A.6
Washington, M.K.7
Subbaramaiah, K.8
Siegel, B.S.9
Young, S.M.10
Dannenberg, A.J.11
Marnett, L.J.12
-
46
-
-
84858036972
-
Overexpression of aldo-keto reductase 1C3 (AKR1C3) in LNCaP cells diverts androgen metabolism towards testosterone resulting in resistance to the 5α-reductase inhibitor finasteride
-
Byrns, M. C.; Mindnich, R.; Duan, L.; Penning, T. M. Overexpression of aldo-keto reductase 1C3 (AKR1C3) in LNCaP cells diverts androgen metabolism towards testosterone resulting in resistance to the 5α-reductase inhibitor finasteride J. Steroid Biochem. Mol. Biol. 2012, 130, 7-15
-
(2012)
J. Steroid Biochem. Mol. Biol.
, vol.130
, pp. 7-15
-
-
Byrns, M.C.1
Mindnich, R.2
Duan, L.3
Penning, T.M.4
-
47
-
-
84875696537
-
Crystal structures of human 17β-hydroxysteroid dehydrogenase Type 5 (AKR1C3) in complex with N -phenylanthranilic acid and indomethacin-based selective inhibitors
-
Chen, M.; Adeniji, A. O.; Twenter, B. M.; Liedtke, A. J.; Winkler, J. D.; Marnett, L. J.; Christianson, D. W.; Penning, T. M. Crystal structures of human 17β-hydroxysteroid dehydrogenase Type 5 (AKR1C3) in complex with N -phenylanthranilic acid and indomethacin-based selective inhibitors Endocr. Rev. 2012, 33, 536
-
(2012)
Endocr. Rev.
, vol.33
, pp. 536
-
-
Chen, M.1
Adeniji, A.O.2
Twenter, B.M.3
Liedtke, A.J.4
Winkler, J.D.5
Marnett, L.J.6
Christianson, D.W.7
Penning, T.M.8
-
48
-
-
1442276491
-
Crystal structure of human prostaglandin F synthase (AKR1C3)
-
Komoto, J.; Yamada, T.; Watanabe, K.; Takusagawa, F. Crystal structure of human prostaglandin F synthase (AKR1C3) Biochemistry 2004, 43, 2188-2198
-
(2004)
Biochemistry
, vol.43
, pp. 2188-2198
-
-
Komoto, J.1
Yamada, T.2
Watanabe, K.3
Takusagawa, F.4
-
49
-
-
1642357433
-
2 11-ketoreductase (AKR1C3) in complex with the nonsteroidal anti-inflammatory drugs flufenamic acid and indomethacin
-
2 11-ketoreductase (AKR1C3) in complex with the nonsteroidal anti-inflammatory drugs flufenamic acid and indomethacin Cancer Res. 2004, 64, 1802-1810
-
(2004)
Cancer Res.
, vol.64
, pp. 1802-1810
-
-
Lovering, A.L.1
Ride, J.P.2
Bunce, C.M.3
Desmond, J.C.4
Cummings, S.M.5
White, S.A.6
-
50
-
-
3042829462
-
Crystal structures of the multispecific 17β-hydroxysteroid dehydrogenase type 5: Critical androgen regulation in human peripheral tissues
-
Qiu, W.; Zhou, M.; Labrie, F.; Lin, S.-X. Crystal structures of the multispecific 17β-hydroxysteroid dehydrogenase type 5: critical androgen regulation in human peripheral tissues Mol. Endocrinol. 2004, 18, 1798-1807
-
(2004)
Mol. Endocrinol.
, vol.18
, pp. 1798-1807
-
-
Qiu, W.1
Zhou, M.2
Labrie, F.3
Lin, S.-X.4
-
51
-
-
1442276491
-
Crystal Structure of human prostaglandin F synthase (AKR1C3)
-
Yamada, T.; Watanabe, K.; Takusagawa, F. Crystal Structure of human prostaglandin F synthase (AKR1C3) Biochemistry 2004, 43, 2188-2198
-
(2004)
Biochemistry
, vol.43
, pp. 2188-2198
-
-
Yamada, T.1
Watanabe, K.2
Takusagawa, F.3
-
52
-
-
79957722662
-
Inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3): Overview and structural insights
-
Byrns, M. C.; Jin, Y.; Penning, T. M. Inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3): overview and structural insights J. Steroid Biochem. Mol. Biol. 2011, 125, 95-104
-
(2011)
J. Steroid Biochem. Mol. Biol.
, vol.125
, pp. 95-104
-
-
Byrns, M.C.1
Jin, Y.2
Penning, T.M.3
-
53
-
-
0000243829
-
PROCHECK: A program to check the stereochemical quality of protein structures
-
Laskowski, R.; MacArthur, A.; Moss, D.; Thornton, J. PROCHECK: a program to check the stereochemical quality of protein structures J. Appl. Crystallogr. 1993, 26, 283-291
-
(1993)
J. Appl. Crystallogr.
, vol.26
, pp. 283-291
-
-
Laskowski, R.1
MacArthur, A.2
Moss, D.3
Thornton, J.4
-
54
-
-
10644285687
-
Molecular basis of the time-dependent inhibition of cyclooxygenases by indomethacin
-
Prusakiewicz, J. J.; Felts, A. S.; Mackenzie, B. S.; Marnett, L. J. Molecular basis of the time-dependent inhibition of cyclooxygenases by indomethacin Biochemistry 2004, 43, 15439-45
-
(2004)
Biochemistry
, vol.43
, pp. 15439-15445
-
-
Prusakiewicz, J.J.1
Felts, A.S.2
MacKenzie, B.S.3
Marnett, L.J.4
-
55
-
-
84865469114
-
Crystal structures of three classes of non-steroidal anti-inflammatory drugs in complex with aldo-keto reductase 1C3
-
Flanagan, J. U.; Yosaatmadja, Y.; Teague, R. M.; Chai, M. Z.; Turnbull, A. P.; Squire, C. J. Crystal structures of three classes of non-steroidal anti-inflammatory drugs in complex with aldo-keto reductase 1C3 PLoS ONE 2012, 7, e43965
-
(2012)
PLoS ONE
, vol.7
, pp. 43965
-
-
Flanagan, J.U.1
Yosaatmadja, Y.2
Teague, R.M.3
Chai, M.Z.4
Turnbull, A.P.5
Squire, C.J.6
-
56
-
-
76149120388
-
AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading
-
Trott, O.; Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading J. Comput. Chem. 2010, 31, 455-461
-
(2010)
J. Comput. Chem.
, vol.31
, pp. 455-461
-
-
Trott, O.1
Olson, A.J.2
-
57
-
-
18144448277
-
Engineering steroid hormone specificity into aldo-keto reductases
-
Penning, T. M.; Ma, H.; Jez, J. M. Engineering steroid hormone specificity into aldo-keto reductases Chem. Biol. Interact. 2001, 130-132, 659-671
-
(2001)
Chem. Biol. Interact.
, vol.130-132
, pp. 659-671
-
-
Penning, T.M.1
Ma, H.2
Jez, J.M.3
-
58
-
-
79957548165
-
Activities of aldo-keto reductase 1 enzymes on two inhaled corticosteroids: Implications for the pharmacological effects of inhaled corticosteroids
-
Jin, Y. Activities of aldo-keto reductase 1 enzymes on two inhaled corticosteroids: implications for the pharmacological effects of inhaled corticosteroids Chem. Biol. Interact. 2011, 191, 234-238
-
(2011)
Chem. Biol. Interact.
, vol.191
, pp. 234-238
-
-
Jin, Y.1
-
59
-
-
0141786953
-
Development of a custom high-throughput preparative liquid chromatography/mass spectrometer platform for the preparative purification and analytical analysis of compound libraries
-
Leister, W.; Strauss, K.; Wisnoski, D.; Zhao, Z.; Lindsley, C. Development of a custom high-throughput preparative liquid chromatography/mass spectrometer platform for the preparative purification and analytical analysis of compound libraries J. Comb. Chem. 2003, 5, 322-329
-
(2003)
J. Comb. Chem.
, vol.5
, pp. 322-329
-
-
Leister, W.1
Strauss, K.2
Wisnoski, D.3
Zhao, Z.4
Lindsley, C.5
-
60
-
-
57449083407
-
Oxidation of PAH trans- dihydrodiols by human aldo-keto reductase AKR1B10
-
Quinn, A. M.; Harvey, R. G.; Penning, T. M. Oxidation of PAH trans- dihydrodiols by human aldo-keto reductase AKR1B10 Chem. Res. Toxicol. 2008, 21, 2207-2215
-
(2008)
Chem. Res. Toxicol.
, vol.21
, pp. 2207-2215
-
-
Quinn, A.M.1
Harvey, R.G.2
Penning, T.M.3
-
61
-
-
0030087578
-
Expression purification and characterization of recombinant human inducible prostaglandin G/H synthase from baculovirus-infected insect cells
-
George, H. J.; Van Dyk, D. E.; Straney, R. A.; Trzaskos, J. M.; Copeland, R. A. Expression purification and characterization of recombinant human inducible prostaglandin G/H synthase from baculovirus-infected insect cells Protein Expression Purif. 1996, 7, 19-26
-
(1996)
Protein Expression Purif.
, vol.7
, pp. 19-26
-
-
George, H.J.1
Van Dyk, D.E.2
Straney, R.A.3
Trzaskos, J.M.4
Copeland, R.A.5
-
62
-
-
0034161787
-
Purification and characterization of the human recombinant histidine-tagged prostaglandin endoperoxide H synthases-1 and -2
-
Smith, T.; Leipprandt, J.; DeWitt, D. Purification and characterization of the human recombinant histidine-tagged prostaglandin endoperoxide H synthases-1 and -2 Arch. Biochem. Biophys. 2000, 375, 195-200
-
(2000)
Arch. Biochem. Biophys.
, vol.375
, pp. 195-200
-
-
Smith, T.1
Leipprandt, J.2
Dewitt, D.3
-
63
-
-
0031059866
-
Processing of X-ray diffraction data collected in oscillation mode
-
Otwinowski, Z.; Minor, M. Processing of X-ray diffraction data collected in oscillation mode Methods Enzymol. 1997, 276, 307-326
-
(1997)
Methods Enzymol.
, vol.276
, pp. 307-326
-
-
Otwinowski, Z.1
Minor, M.2
-
64
-
-
34447508216
-
Phaser crystallographic software
-
McCoy, A. J.; Grosse-Kunstleve, R. W.; Adams, P. D.; Winn, M. D.; Storoni, L. C.; Read, R. J. Phaser crystallographic software J. Appl. Crystallogr. 2007, 40, 658-674
-
(2007)
J. Appl. Crystallogr.
, vol.40
, pp. 658-674
-
-
McCoy, A.J.1
Grosse-Kunstleve, R.W.2
Adams, P.D.3
Winn, M.D.4
Storoni, L.C.5
Read, R.J.6
-
65
-
-
3543012707
-
Crystallography and NMR system: A new software system for macromolecular structure determination
-
Brunger, A. T.; Adams, P. D.; Clore, G. M.; Delano, W. L.; Gros, P.; Grosse-Kunstleve, R. W.; Jiang, J.-S.; Kuszewski, J.; Nilges, N.; Pannu, N. S.; Read, R. J.; Rice, L. M.; Simonson, T.; Warren, G. L. Crystallography and NMR system: a new software system for macromolecular structure determination Acta Crystallogr. 1998, 54, 905-921
-
(1998)
Acta Crystallogr.
, vol.54
, pp. 905-921
-
-
Brunger, A.T.1
Adams, P.D.2
Clore, G.M.3
Delano, W.L.4
Gros, P.5
Grosse-Kunstleve, R.W.6
Jiang, J.-S.7
Kuszewski, J.8
Nilges, N.9
Pannu, N.S.10
Read, R.J.11
Rice, L.M.12
Simonson, T.13
Warren, G.L.14
-
66
-
-
76449098262
-
PHENIX: A comprehensive Python-based system for macromolecular structure solution
-
Adams, P. D.; Afonine, P. V.; Bunkóczi, G.; Chen, V. B.; Davis, I. W.; Echols, N.; Headd, J. J.; Hung, L.-W.; Kapral, G. J.; Grosse-Kunstleve, R. W.; McCoy, A. J.; Moriarty, N. W.; Oeffner, R.; Read, R. J.; Richardson, D. C.; Richardson, J. S.; Terwilliger, T. C.; Zwart, P. H. PHENIX: a comprehensive Python-based system for macromolecular structure solution Acta Crystallogr., Sect. D: Biol. Crystallogr. 2010, 66, 213-221
-
(2010)
Acta Crystallogr., Sect. D: Biol. Crystallogr.
, vol.66
, pp. 213-221
-
-
Adams, P.D.1
Afonine, P.V.2
Bunkóczi, G.3
Chen, V.B.4
Davis, I.W.5
Echols, N.6
Headd, J.J.7
Hung, L.-W.8
Kapral, G.J.9
Grosse-Kunstleve, R.W.10
McCoy, A.J.11
Moriarty, N.W.12
Oeffner, R.13
Read, R.J.14
Richardson, D.C.15
Richardson, J.S.16
Terwilliger, T.C.17
Zwart, P.H.18
-
67
-
-
13244281317
-
Coot: Model-building tools for molecular graphics
-
Emsley, P.; Cowtan, K. Coot: model-building tools for molecular graphics Acta Crystallogr. 2004, 60, 2126-2132
-
(2004)
Acta Crystallogr.
, vol.60
, pp. 2126-2132
-
-
Emsley, P.1
Cowtan, K.2
|